Ultrastructural analysis of the growth cycle of Chlamydia trachomatis in mouse cells treated with recombinant human alpha-interferons - PubMed (original) (raw)
Ultrastructural analysis of the growth cycle of Chlamydia trachomatis in mouse cells treated with recombinant human alpha-interferons
L M de la Maza et al. Exp Mol Pathol. 1984 Oct.
Abstract
The effect of two recombinant human hybrid interferons (IFNs), IFN-alpha AD (BglII) and IFN-alpha DA (BglII), on the growth cycle of Chlamydia trachomatis in a murine (McCoy) cell line was investigated. Ultrastructural analysis indicated that IFN-alpha AD inhibited the growth of chlamydia while IFN-alpha DA-treated cells did not significantly differ from the control monolayers. Treatment of the chlamydia-infected monolayers with IFN-alpha AD resulted in an inhibition in the transformation of elementary bodies to reticulate bodies with a consequent marked decrease in the number of chlamydia inclusions. Furthermore, chlamydial inclusions in the IFN-alpha AD-treated cells contained fewer and more immature chlamydial forms than the control or the IFN-alpha DA-treated cells. Secondary infection occurred in the IFN-alpha DA and in the control monolayer, but no such phenomena was detected in the IFN-alpha AD-treated McCoy cells indicating a loss of infectivity of the chlamydial organisms. From this study it can be concluded that purified recombinant human hybrid IFNs may exert an inhibitory effect on the growth cycle of C. trachomatis in a mouse cell line. This inhibition occurs primarily at the point of transformation from elementary to reticulate body.
Similar articles
- Interferon-induced inhibition of Chlamydia trachomatis: dissociation from antiviral and antiproliferative effects.
de la Maza LM, Peterson EM, Goebel JM, Fennie CW, Czarniecki CW. de la Maza LM, et al. Infect Immun. 1985 Mar;47(3):719-22. doi: 10.1128/iai.47.3.719-722.1985. Infect Immun. 1985. PMID: 3972450 Free PMC article. - Ultrastructural analysis of the anti-chlamydial activity of recombinant murine interferon-gamma.
de la Maza LM, Plunkett MJ, Carlson EJ, Peterson EM, Czarniecki CW. de la Maza LM, et al. Exp Mol Pathol. 1987 Aug;47(1):13-25. doi: 10.1016/0014-4800(87)90003-7. Exp Mol Pathol. 1987. PMID: 3111877 - Accelerated development of genital Chlamydia trachomatis serovar E in McCoy cells grown on microcarrier beads.
Wyrick PB, Gerbig DG Jr, Knight ST, Raulston JE. Wyrick PB, et al. Microb Pathog. 1996 Jan;20(1):31-40. doi: 10.1006/mpat.1996.0003. Microb Pathog. 1996. PMID: 8692008 - Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes.
Koehler L, Nettelnbreker E, Hudson AP, Ott N, Gérard HC, Branigan PJ, Schumacher HR, Drommer W, Zeidler H. Koehler L, et al. Microb Pathog. 1997 Mar;22(3):133-42. doi: 10.1006/mpat.1996.0103. Microb Pathog. 1997. PMID: 9075216 - Implications for persistent chlamydial infections of phagocyte-microorganism interplay.
Sarov I, Geron E, Shemer-Avni Y, Manor E, Zvillich M, Wallach D, Schmitz E, Holtman H. Sarov I, et al. Eur J Clin Microbiol Infect Dis. 1991 Feb;10(2):119-23. doi: 10.1007/BF01964423. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1907541 Review.
Cited by
- Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron.
Slepenkin A, Enquist PA, Hägglund U, de la Maza LM, Elofsson M, Peterson EM. Slepenkin A, et al. Infect Immun. 2007 Jul;75(7):3478-89. doi: 10.1128/IAI.00023-07. Epub 2007 Apr 30. Infect Immun. 2007. PMID: 17470544 Free PMC article. - Interferon-induced inhibition of Chlamydia trachomatis: dissociation from antiviral and antiproliferative effects.
de la Maza LM, Peterson EM, Goebel JM, Fennie CW, Czarniecki CW. de la Maza LM, et al. Infect Immun. 1985 Mar;47(3):719-22. doi: 10.1128/iai.47.3.719-722.1985. Infect Immun. 1985. PMID: 3972450 Free PMC article. - Recombinant murine gamma interferon inhibits Chlamydia trachomatis serovar L1 in vivo.
Zhong GM, Peterson EM, Czarniecki CW, de la Maza LM. Zhong GM, et al. Infect Immun. 1988 Jan;56(1):283-6. doi: 10.1128/iai.56.1.283-286.1988. Infect Immun. 1988. PMID: 3121513 Free PMC article. - The antichlamydial, antiviral, and antiproliferative activities of human gamma interferon are dependent on the integrity of the C terminus of the interferon molecule.
de la Maza LM, Peterson EM, Burton LE, Gray PW, Rinderknecht E, Czarniecki CW. de la Maza LM, et al. Infect Immun. 1987 Nov;55(11):2727-33. doi: 10.1128/iai.55.11.2727-2733.1987. Infect Immun. 1987. PMID: 3117689 Free PMC article. - Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections.
Zhong GM, Peterson EM, Czarniecki CW, Schreiber RD, de la Maza LM. Zhong GM, et al. Infect Immun. 1989 Jan;57(1):152-7. doi: 10.1128/iai.57.1.152-157.1989. Infect Immun. 1989. PMID: 2491833 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical